Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Corticosteroid therapy for pneumonia

Respiratory tract infections (RTIs) cause millions of deaths worldwide each year.1 Despite the availability of appropriate antibiotic therapy, treatment of all forms of RTIs is associated with major long-term morbidity and mortality. This outcome could be attributable to excessive, sustained inflammatory responses with consequential pulmonary damage, dampening of effective immune responses, and pulmonary dysfunction, all of which retard recovery and cure. Adjunct, host-directed therapies that modulate destructive inflammatory responses could improve morbidity and mortality rates and prevent serious long-term sequelae.